My "Morning Wire" Newsletter from The Daily Wire had a story about this this morning.
(It gets a little bit political, so I hope it's okay to post it here. It's a podcast, but this is the print version sent to subscribers.)
The headline says:
Biden Administration Quiet On Effective Antibody Treatment The Topline: Monoclonal antibody treatment, which is reportedly safe and free for patients, has been shown to reduce chances of hospitalization and death for those infected with Covid, but has gone largely unmentioned by the White House COVID-19 Response Team.
Quote Of The Day: "It is befuddling to me...to see that the Biden administration is not touting this treatment as an effective means... regardless of vaccination status, I think they have put all of their eggs in one basket."
Florida Lieutenant Governor Jeanette Nunez
What Is Monoclonal Antibody Treatment?The treatment is essentially an infusion of supplemental lab-created antibodies which help someone's body fight off Covid.
University of Alabama at Birmingham Professor Turner Overton explained the treatment, saying your "immune system takes two to three weeks to make good antibodies," but "monoclonal antibodies are supplemental antibodies which can be administered early in the course of infection the first 10 days after symptoms commence to rapidly bind and kill the COVID virus."
The treatment has been
authorized by the FDA for emergency use since November 2020, and has been widely praised by doctors and others in the medical field, including from the federal government.
Word Isn't Getting OutThe most prominent company providing the treatment is Regeneron Pharmaceuticals who have teamed up with the federal government to pass along the treatment to Americans for free, but the extent of their patient reach is extremely low.
In late August, the company said it was reaching fewer than 30% of eligible patients which was up from its numbers in July, when Regeneron reached fewer than 5% of eligible patients.
Why The Low Reach?The lack of awareness about the treatment has been largely pinned on the Biden administration.
Former FDA commissioner Mark McClellan told The Washington Post in August, "access is still uneven and way below the number of people who could potentially benefit."
The Biden administration has taken "some very important steps," McClellan said, but notably admitted "there is still a big gap, an opportunity to get more people treated and get control of the pandemic."
The Political SideEven though the treatment has shown a lot of success, the White House doesn't appear to be focused on promoting it.
Last week, Florida Governor Ron DeSantis (R) who's been promoting both the vaccine and early care like antibody treatment suggested public health officials haven't promoted the treatment because they've feared if Americans knew about it, they might not get the vaccine.
DeSantis emphasized the importance of vaccination but criticized those who are, in his opinion, neglecting to inform the public about all their options and care.
The "Trump Factor"Americans likely first heard of antibody treatment from former President Donald Trump when he received it and made a quick turnaround. The media slammed Trump for calling the treatment a "cure," and since then, they seem timid to discuss the treatment which could be a factor in Biden's hesitancy to talk about it, as well.
Where Can Americans Find It?The treatment is available in all 50 states. While this should be done in concert with your doctor, Americans can check where these treatments have been shipped. The U.S. Department of Health and Human Services has a user-friendly map for the public on
their website.
If I’m posting, it’s actually Mrs GeographyAg.
Mr. GeographyAg is a dedicated lurker.